Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$839,559,588
+$142,593,324 QoQ
Shares Held
23,723,074
-5.7% QoQ
Ownership
3.28%
of shares outstanding
% of Portfolio
55.14%
of 13F equity value
Holder Rank
#4
of 494 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026QVT Financial LP holds $891,038,394 across 8 Biotechnology names. ROIV ranks #1 (94.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
This page
|
23,723,074 | $839,559,588 | |
| 2 | WHWK |
Whitehawk Therapeutics, Inc.
|
4,615,709 | $21,139,947 | |
| 3 | ZURA |
Zura Bio Ltd
|
1,895,153 | $11,181,402 | |
| 4 | BHVN |
Biohaven Ltd.
|
354,206 | $5,270,585 | |
| 5 | SMMT |
Summit Therapeutics Inc.
|
360,524 | $5,252,834 | |
| 6 | ARGX |
Argenx SE
|
5,218 | $4,841,103 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
678,564 | $2,822,826 | |
| 8 | NUVB |
Nuvation Bio Inc.
|
170,794 | $970,109 |
All Filings in ROIV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $839,559,588 | 23,723,074 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $696,966,264 | 25,161,237 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $572,598,355 | 26,387,021 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $444,544,137 | 29,381,635 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $331,131,026 | 29,381,635 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $331,131,026 | 29,381,635 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $663,859,230 | 65,793,779 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $778,340,405 | 65,793,779 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $778,340,405 | 65,793,779 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $759,260,209 | 65,793,779 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $705,228,064 | 66,719,779 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $703,226,470 | 66,719,779 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,263,841,449 | 112,541,536 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,314,485,140 | 112,541,536 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,235,218,682 | 122,541,536 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $904,356,535 | 122,541,536 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $979,106,872 | 122,541,536 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $416,648,090 | 129,393,817 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $526,632,835 | 129,393,817 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $639,205,455 | 129,393,817 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,304,289,675 | 129,393,817 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||